Platelet Rich Plasma for Musculoskeletal Conditions
NCT: NCT07231471 · RECRUITING
Brief Summary
The primary purpose of this study is to follow patients with various musculoskeletal (MSK) conditions over a one-year follow-up period after receiving a platelet rich plasma (PRP) injection, assessing changes in their pain levels, functional abilities, and overall patient satisfaction. This will develop a robust registry of patients treated with PRP for a range of MSK conditions. These conditions include, but are not limited to, osteoarthritis (OA) of the knee, hip, glenohumeral joint, elbow, ankle, and sacroiliac joint, as well as rotator cuff tendinopathy, lateral and medial epicondylitis, plantar fasciitis, patellar tendinopathy, Achilles tendinopathy, and proximal hamstring tendinopathy.
Frequently Asked Questions
What is Platelet Rich Plasma for Musculoskeletal Conditions?
Platelet Rich Plasma for Musculoskeletal Conditions is a clinical trial registered under NCT07231471. Current status: RECRUITING.
What is the status of NCT07231471?
The current status of NCT07231471 (Platelet Rich Plasma for Musculoskeletal Conditions) is: RECRUITING.
When did Platelet Rich Plasma for Musculoskeletal Conditions start?
Platelet Rich Plasma for Musculoskeletal Conditions started on 2025-12-29.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.